Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.56 USD
+0.12 (8.33%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.55 -0.01 (-0.64%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 32% (81 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.70 | 9.99 |
Current Quarter Estimate | -0.20 | 4.85 | 61.00 |
Year Ago Quarter Estimate | -0.27 | 3.57 | 54.84 |
Next Quarter Estimate | -0.21 | 5.64 | 63.00 |
Next Year Estimate | -0.69 | 24.53 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 13.51 | 12.60 | 15.67 |
Next Year | 28.13 | 22.50 | 11.34 |
Last 5 Years | -270.30 | 10.20 | 8.10 |
Next 5 Years | NA | 13.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 8.00 |
Price/Book (MRQ) | 0.86 | 2.42 |
Price/Cash Flow (MRFY) | NA | 17.30 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -211.99% | -29.53% |
Return on Equity (TTM) | -40.98% | -24.89% |
Debt to Equity (MRQ) | 1.81 | 10.32 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.